Search Results - "Armstrong, DK"

The role of nonrandomized trials in the evaluation of oncology drugs by Simon, R, Blumenthal, GM, Rothenberg, ML, Sommer, J, Roberts, SA, Armstrong, DK, LaVange, LM, Pazdur, R

“…Although randomized trials provide the most reliable evidence of a drug's safety and efficacy, there are situations where randomized trials are not possible or…”
Get full text

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer by Armstrong, Deborah K, Bundy, Brian, Wenzel, Lari, Huang, Helen Q, Baergen, Rebecca, Lele, Shashikant, Copeland, Larry J, Walker, Joan L, Burger, Robert A

“…In a trial of adjuvant chemotherapy for ovarian cancer, a regimen of intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel was superior to…”
Get full text

Relapsed Ovarian Cancer: Challenges and Management Strategies for a Chronic Disease by Armstrong, Deborah K.

“…Learning Objectives After completing this course, the reader will be able to: Better appreciate the challenges faced in managing treatment of patients with…”
Get full text

Abstract P6-08-12: Understanding the etiology of osteopenia and osteoporosis in young breast cancer survivors compared to cancer-free women by Ramin, CA, May, BJ, Roden, RBS, McCullough, M, Armstrong, DK, Visvanathan, K

“…Background: Our group previously reported that young breast cancer (BC) survivors have a higher risk of osteopenia/osteoporosis compared to their cancer-free…”
Get full text

Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis by Bristow, R. E.

Get full text

Topotecan Dosing Guidelines in Ovarian Cancer: Reduction and Management of Hematologic Toxicity by Armstrong, Deborah K.

“…Learning Objectives After completing this course, the reader will be able to: Describe the hematologic safety profile of topotecan in patients with relapsed…”
Get full text

Risk of Epithelial Ovarian Cancer Recurrence in Patients With Rising Serum CA-125 Levels Within the Normal Range by SANTILLAN, Antonio, GARG, Ruchi, ZAHURAK, Marianna L, GARDNER, Ginger J, GIUNTOLI, Robert L, ARMSTRONG, Deborah K, BRISTOW, Robert E

“…To evaluate the risk of epithelial ovarian cancer (EOC) recurrence in patients with rising serum cancer antigen 125 (CA-125) levels that remain below the upper…”
Get full text

Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study by Whitney, Charles W, Brunetto, Virginia L, Zaino, Richard J, Lentz, Samuel S, Sorosky, Joel, Armstrong, Deborah K, Lee, Roger B

“…Objectives. The objectives of this study were to estimate the clinical response rate and toxicity of daily tamoxifen combined with intermittent weekly…”
Get full text

Comparison of HPV DNA vaccines employing intracellular targeting strategies by KIM, J. W, HUNG, C-F, WU, T-C, JUANG, J, HE, L, WOO KIM, T, ARMSTRONG, D. K, PAI, S. I, CHEN, P-J, LIN, C-T, BOYD, D. A

“…Intradermal vaccination via gene gun efficiently delivers DNA vaccines into dendritic cells (DCs) of the skin, resulting in the activation and priming of…”
Get full text

Hematologic Safety and Tolerability of Topotecan in Recurrent Ovarian Cancer and Small Cell Lung Cancer: An Integrated Analysis by Armstrong, Deborah K., Spriggs, David, Levin, Jeremey, Poulin, Ruth, Lane, Stephen

“…Learning Objectives After completing this course, the reader will be able to: Explain the approved indications and treatment schedules for topotecan. Describe…”
Get full text

Surgical care of elderly women with ovarian cancer: A population-based perspective by Díaz-Montes, Teresa P., Zahurak, Mariana L., Giuntoli, Robert L., Gardner, Ginger J., Gordon, Toby A., Armstrong, Deborah K., Bristow, Robert E.

“…To characterize the primary surgical care and short-term outcomes for ovarian cancer in women aged 80 years and older compared to women younger than 80 years…”
Get full text

Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group by Williams, Stephen D., Kauderer, James, Burnett, Alexander F., Lentz, Samuel S., Aghajanian, Carol, Armstrong, Deborah K.

“…This study was designed to evaluate the effect of adjuvant chemotherapy with carboplatin and etoposide in patients with completely resected stage IB–III…”
Get full text

Breast cancer risk reduction by Bevers, Therese B, Armstrong, Deborah K, Arun, Banu, Carlson, Robert W, Cowan, Kenneth H, Daly, Mary B, Fleming, Irvin, Garber, Judy E, Gemignani, Mary, Gradishar, William J, Krontiras, Helen, Kulkarni, Swati, Laronga, Christine, Loftus, Loretta, Macdonald, Deborah J, Mahoney, Martin C, Merajver, Sofia D, Meszoely, Ingrid, Newman, Lisa, Pritchard, Elizabeth, Seewaldt, Victoria, Sellin, Rena V, Shapiro, Charles L, Ward, John H

Get more information

Novel Therapies in Ovarian Cancer Management: An Update on the Role of Topotecan by Armstrong, Deborah K.

Get full text

Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapy by Rudek, M.A, Sparreboom, A, Garrett-Mayer, E.S, Armstrong, D.K, Wolff, A.C, Verweij, J, Baker, S.D

“…Current dosing strategies for anticancer drugs result in wide interindividual pharmacokinetic variability. Here, we explored the influence of age, body size,…”
Get full text

Clinical significance of Her-2/neu overexpression in uterine serous carcinoma by Díaz-Montes, Teresa P., Ji, Hongxiu, Smith Sehdev, Ann E., Zahurak, Mariana L., Kurman, Robert J., Armstrong, Deborah K., Bristow, Robert E.

“…To evaluate the clinico-pathologic characteristics and survival outcome associated with overexpression of Her-2/neu in patients with uterine serous carcinoma…”
Get full text

Recurrent micropapillary serous ovarian carcinoma: The role of secondary cytoreductive surgery by BRISTOW, Robert E, GOSSETT, Dana R, SHOOK, David R, ZAHURAK, Mariana L, TOMACRUZ, Rafael S, ARMSTRONG, Deborah K, MONTZ, Fredrick J

Get full text

Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis by May, W S, Tyler, P G, Ito, T, Armstrong, D K, Qatsha, K A, Davidson, N E

“…Using murine myeloid factor-dependent FDC-P1/ER cells, we demonstrate that the hematopoietic growth factors interleukin-3 and erythropoietin and bryostatin-1,…”
Get full text

Abdominal carcinomatosis in women with a history of breast cancer by Garg, Ruchi, Zahurak, Mariana L., Trimble, Edward L., Armstrong, Deborah K., Bristow, Robert E.

“…The goals of this study were to: (1) characterize the etiology of abdominal carcinomatosis, (2) identify clinical features predictive of primary…”
Get full text

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms by McGuire, W P, Rowinsky, E K, Rosenshein, N B, Grumbine, F C, Ettinger, D S, Armstrong, D K, Donehower, R C

“…To assess the activity of taxol in patients with advanced, progressive, and drug-refractory ovarian cancer and to delineate more clearly the toxicity of taxol…”
Get more information